PREVIOUS MEETING

ISOPP IV
28.2-3.3.2002
Seville, Spain

ABSTRACTS NOW ONLINE

as of February 2004

Drug Development Clinical studies and Ethics Ophthalmology drugs - market analysis Glaucoma IOP Lowering Agents Blood Flow  Neuroprotection  Inflammation and Infection Immunomodulatory Therapy Evidence Based Medicine Biologics Session Ocular Allergy Antimicrobial Resistance: Mechanisms and Magnitude in Ophthalmology Basic Science Genetics: Basic Concepts for Clinicians Apoptosis Neuroprotection of Ocular Diseases Inhibition of Angiogenesis Antioxidants

Retina Diabetic Macular Edema Angiogenesis Inhibition Treatments Prevention of PDR PDT New Drugs  Targeting the Vitreous Triamcinolone Acetonide Others Anterior Segment  Immunology of the Ocular Surface  Ocular Surface Disease/Dry Eyes Toxicology and Drug Delivery Ocular Toxicology Drug Delivery Disease Progression Detection  Glaucoma Endpoints  Retina Endpoints Cutting Edge Imaging Techniques  Companies’ Sessions Allergan B & L MSD Novartis Pfizer Senju